Alterity Therapeutics Limited Stock News

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has presented data on ATH434 (formerly PBT434) for the treatment of Multiple System Atrophy at the American Academy of Neur

They say on Wall Street that if you want to make a small fortune, start by investing a large one.The billionaires and big-time money managers below all have fortunes of various sizes, and studying whi

Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") releases its Appendix 4C Quarterly Cash Flow Report and update on company activities for the quarter ending 31 Marc

In 2005, Geoffrey Kempler was appointed CEO of Alterity Therapeutics Limited (ASX:ATH). This analysis aims first to...

As they shelter in place, cash-strapped millennial parents can still save for college while they shop from major online retailers with its new Backer Bucks program, leading college savings platform Co

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Be

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) * Biomerica, Inc. (NASDAQ: BMRA)( announced comm

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 4) * 89bio Inc (NASDAQ: ETNB) * Arcus Biosciences In

It's nice to see the Alterity Therapeutics Limited (ASX:ATH) share price up 12% in a week. But spare a thought for the...

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 13.) Arvinas Inc (NASDAQ: ARVN ) Baxter Int

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

In 2005 Geoffrey Kempler was appointed CEO of Alterity Therapeutics Limited (ASX:ATH). This report will, first...

Long term investing works well, but it doesn't always work for each individual stock. We don't wish catastrophic...